Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 9/30/2019 | 6/30/2019 | 3/31/2019 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.07 | 0.00 | 0.80 |
| FCF Yield | -25.90% | 18.77% | -7.40% | -2.88% |
| EV / EBITDA | 62.33 | 5.60 | -21.41 | 15.92 |
| Quality | ||||
| ROIC | 0.32% | 6.35% | -7.24% | 3.05% |
| Gross Margin | 16.28% | 23.46% | 29.03% | 22.80% |
| Cash Conversion Ratio | 0.02 | 5.90 | 0.44 | -1.38 |
| Growth | ||||
| Revenue 3-Year CAGR | 15.37% | 34.64% | 27.80% | 35.99% |
| Free Cash Flow Growth | -106.32% | 281.66% | -90.79% | -265.74% |
| Safety | ||||
| Net Debt / EBITDA | 53.82 | 0.28 | -2.62 | 0.79 |
| Interest Coverage | 0.03 | 1.35 | -0.89 | 3.88 |
| Efficiency | ||||
| Inventory Turnover | 229.45 | 59.47 | 67.64 | 62.83 |
| Cash Conversion Cycle | 21.72 | 5.98 | 0.74 | 43.25 |